In patients over 20 years of age with a diagnosis of hyperphosphaturic hypophosphatemic OM and elevated FGF23 levels, without clinical manifestations suspicious of genetic origin, TIO should be suspected, and imaging tests be ordered to locate the possible FGF23-secreting tumor. This evidence concerns the gene FGF23 and neoplasm.